Federal Register / Vol. 87, No. 1 / Monday, January 3, 2022 / Notices 103 

Diana Espinosa, 

Acting Administrator. 

[FR Doc. 2021–28377 Filed 12–30–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: Public 

Comment Request Rural Health Clinic 

COVID–19 Reporting Portal, OMB No. 

0906–0056—Revision 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects of the Paperwork Reduction Act 

of 1995, HRSA announces plans to 

submit an Information Collection 

Request (ICR), described below, to the 

Office of Management and Budget 

(OMB). Prior to submitting the ICR to 

OMB, HRSA seeks comments from the 

public regarding the burden estimate, 

below, or any other aspect of the ICR. 

DATES: Comments on this ICR should be 

received no later than March 4, 2022. 

ADDRESSES: Submit your comments to 

paperwork@hrsa.gov or by mail to the 

HRSA Information Collection Clearance 

Officer, Room 14N136B, 5600 Fishers 

Lane, Rockville, MD 20857. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, email paperwork@hrsa.gov 

or call Samantha Miller, the acting 

HRSA Information Collection Clearance 

Officer at (301) 443–9094. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the 

information collection request title for 

reference. 

Information Collection Request Title: 

Rural Health Clinic COVID–19 (RHC 

COVID–19) Reporting Portal OMB No. 

0906–0056—Revision. 

Abstract: In October 2020, HRSA 

created a monthly, aggregate data report 

to collect information on COVID–19 

testing and related expenses conducted 

by funded organizations participating in 

the RHC COVID–19 Testing (RHCCT) 

Program funded through the Paycheck 

Protection Program and Health Care 

Enhancement Act (Pub. L. 116–139). 

HRSA is expanding this data report to 

collect information on COVID–19 

testing, COVID–19 mitigation, and 

related expenses conducted by funded 

organizations participating in the RHC 

COVID–19 Testing and Mitigation 

(RHCCTM) Program funded through the 

American Rescue Plan Act (Pub. L. 117– 

2). Funded organizations were 

identified by Tax Identification Number 

(TIN), and a TIN organization may 

operate one or more RHC sites which 

were identified by unique Centers for 

Medicare and Medicaid Services 

Certification Numbers. Respondents are 

TIN organizations who received funding 

for COVID–19 testing, COVID–19 

mitigation, and related expenses. HRSA 

issued RHCCTM funding as one-time 

payments to 2,301 TIN organizations 

based on the number of certified RHC 

sites they operate, providing $100,000 

per clinic site (4,459 RHC sites total 

across the country). Data report 

information is needed to comply with 

federal requirements to monitor funds 

distributed under the Paycheck 

Protection Program and Health Care 

Enhancement Act and the American 

Rescue Plan Act. 

Need and Proposed Use of the 

Information: The RHC COVID–19 

Reporting Portal collects information 

from RHC-funded providers who use 

RHCCT Program funding and RHCCTM 

Program funding to support COVID–19 

testing, expand access to testing in rural 

communities, and other related 

expenses. The RHC COVID–19 

Reporting Portal also collects 

information from RHC-funded providers 

who use RHCCTM Program funding to 

support COVID–19 mitigation and other 

related expenses. These data are critical 

to meet HRSA requirements to monitor 

and report on how federal funding is 

being used and to measure the 

effectiveness of the RHCCT Program and 

RHCCTM Program. Revisions include a 

confirmation page for TIN organization 

self-certification following completion 

of each program after the period of 

availability. Specifically, data will be 

used to assess the following: 

• Whether program funds are being 

spent for their intended purposes; 

• COVID–19 testing or testing related 

use(s) of RHCCTM funds; 

• COVID–19 mitigation or mitigation 

related use(s) of RHCCTM funds; 

• Where COVID–19 testing supported 

by these funds is occurring; 

• Number of at-home (i.e. home 

collection, direct-to-consumer, over-thecounter) COVID–19 tests distributed 

(optional); 

• Number of COVID–19 tests; 

• Number of positive COVID–19 tests; 

• TIN organizations self-certification 

of complete expenditure of RHCCT 

Program funds and/or full or partial 

return of RHCCT Program funds; and 

• TIN organizations self-certification 

of complete expenditure of RHCCTM 

Program funds and/or full or partial 

return of RHCCTM Program funds. 

Likely Respondents: Respondents are 

TIN organizations who own or operate 

one or more RHC who received funding 

for COVID–19 testing, COVID–19 

mitigation, and related expenses. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

RHC COVID–19 Reporting Portal ....................................... 2,301 19 43,719 0.33 14,427 

Total .............................................................................. 2,301 ........................ 43,719 ........................ 14,427 


khammond on DSKJM1Z7X2PROD with NOTICES
104 Federal Register / Vol. 87, No. 1 / Monday, January 3, 2022 / Notices 

HRSA specifically requests comments 

on: (1) The necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–28414 Filed 12–30–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Council on Alzheimer’s 

Research, Care, and Services; Meeting 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

public meeting of the Advisory Council 

on Alzheimer’s Research, Care, and 

Services (Advisory Council). The 

Advisory Council provides advice on 

how to prevent or reduce the burden of 

Alzheimer’s disease and related 

dementias on people with the disease 

and their caregivers. During the January 

24, 2022 meeting the Advisory Council 

will hear about the National Plan to 

Address Alzheimer’s Disease: 2021 

Update, as well as update from federal 

agencies. The Advisory Council will 

also hear presentations about dementia 

risk reduction for veterans and research 

on the potential relationship between 

COVID–19 and dementia. The Advisory 

Council will also hear about a recent 

report on the current capacity of the 

dementia care workforce. A panel will 

present on dementia assessment tools 

for special populations, such as 

individuals with intellectual and 

developmental disabilities. Finally, the 

Advisory Council will hear from a panel 

on the inclusion of caregivers in clinical 

care settings, including those in rural 

communities. 

DATES: The meeting will be held on 

January 24, 2022 from 12:00 p.m. to 4:30 

p.m. EST. 

ADDRESSES: The meeting will be virtual, 

streaming live at www.hhs.gov/live. 

Comments: Time is allocated on the 

agenda to hear public comments from 

4:00 p.m. to 4:30 p.m. The time for oral 

comments will be limited to two (2) 

minutes per individual. In order to 

provide a public comment, please 

register by emailing your name to 

napa@hhs.gov by Thursday, January 20. 

On Friday, January 21, registered 

commenters will receive both a dial-in 

number and a link to join the meeting 

virtually; individuals will have the 

choice to either join virtually via the 

link, or to call in only by using the dialin number. Note: There may be a 30–45 

second delay in the livestream video 

presentation of the conference. For this 

reason, if you have pre-registered to 

submit a public comment, it is 

important to connect to the meeting by 

3:45 p.m. to ensure that you do not miss 

your name and allotted time when 

called. If you miss your name and 

allotted time to speak, you may not be 

able to make your public comment. All 

participant audio lines will be muted for 

the duration of the meeting and only 

unmuted by the Host at the time of the 

participant’s public comment. Should 

you have questions during the session 

email napa@hhs.gov and someone will 

respond to your message as quickly as 

possible. 

In order to ensure accuracy, please 

submit a written copy of oral comments 

for the record by emailing napa@

hhs.gov by Tuesday, January 25. These 

comments will be shared on the website 

and reflected in the meeting minutes. 

In lieu of oral comments, formal 

written comments may be submitted for 

the record by Tuesday, January 25 to 

Helen Lamont, Ph.D., OASPE, 200 

Independence Avenue SW, Room 424E, 

Washington, DC 20201. Comments may 

also be sent to napa@hhs.gov. Those 

submitting written comments should 

identify themselves and any relevant 

organizational affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Helen Lamont, 202–260–6075, 

helen.lamont@hhs.gov. Note: The 

meeting will be available to the public 

live at www.hhs.gov/live. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)(1) and 

(a)(2)). Topics of the Meeting: Long-term 

services and supports workforce, 

caregiving. 

Procedure and Agenda: The meeting 

will be webcast at www.hhs.gov/live and 

video recordings will be added to the 

National Alzheimer’s Project Act 

website when available, after the 

meeting. 

Authority: 42 U.S.C. 11225; Section 

2(e)(3) of the National Alzheimer’s 

Project Act. The panel is governed by 

provisions of Public Law 92–463, as 

amended (5 U.S.C. Appendix 2), which 

sets forth standards for the formation 

and use of advisory committees. 

Dated: December 22, 2021. 

Benjamin Sommers, 

Deputy Assistant Secretary for Planning and 

Evaluation Acting on Behalf of Rebecca 

Haffajee, Acting Assistant Secretary for 

Planning and Evaluation. 

[FR Doc. 2021–28412 Filed 12–30–21; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Genetic 

Variant-based Drug Development for Healthy 

Aging. 

Date: March 2, 2022. 

Time: 11:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C/212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, 301–496–9666, 

parsadaniana@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Glial 

Pathology in Brain Aging. 

Date: March 11, 2022. 

Time: 12:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C/212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, 301–496–9666, 

parsadaniana@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES